| Year |
Citation |
Score |
| 2019 |
Feris EJ, Hinds JW, Cole MD. Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex. Plos One. 14: e0225784. PMID 31790487 DOI: 10.1371/Journal.Pone.0225784 |
0.451 |
|
| 2018 |
Chidawanyika T, Sergison E, Cole M, Mark K, Supattapone S. SEC24A identified as an essential mediator of thapsigargin-induced cell death in a genome-wide CRISPR/Cas9 screen. Cell Death Discovery. 4: 115. PMID 30588337 DOI: 10.1038/S41420-018-0135-5 |
0.343 |
|
| 2017 |
Smits NC, Kobayashi T, Srivastava PK, Skopelja S, Ivy JA, Elwood DJ, Stan RV, Tsongalis GJ, Sellke FW, Gross PL, Cole MD, DeVries JT, Kaplan AV, Robb JF, Williams SM, et al. HS3ST1 Genotype Regulates Antithrombin's Inflammomodulatory Tone and Associates with Atherosclerosis. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 28126521 DOI: 10.1016/J.Matbio.2017.01.003 |
0.742 |
|
| 2016 |
Posternak V, Ung MH, Cheng C, Cole MD. MYC Mediates mRNA Cap Methylation of Canonical Wnt/beta-catenin Signaling Transcripts by Recruiting CDK7 and RNA Methyltransferase. Molecular Cancer Research : McR. PMID 27899423 DOI: 10.1158/1541-7786.Mcr-16-0247 |
0.384 |
|
| 2016 |
Pattison JM, Posternak V, Cole MD. Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk. Molecular Cancer Research : McR. PMID 27514407 DOI: 10.1158/1541-7786.Mcr-16-0123 |
0.733 |
|
| 2016 |
Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, ... ... Cole MD, et al. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics. PMID 27402876 DOI: 10.1093/hmg/ddw223 |
0.72 |
|
| 2016 |
Posternak V, Cole MD. Strategically targeting MYC in cancer. F1000research. 5. PMID 27081479 DOI: 10.12688/F1000Research.7879.1 |
0.385 |
|
| 2015 |
Pattison JM, Wright JB, Cole MD. Retroviruses hijack chromatin loops to drive oncogene expression and highlight the chromatin architecture around proto-oncogenic loci. Plos One. 10: e0120256. PMID 25799187 DOI: 10.1371/Journal.Pone.0120256 |
0.771 |
|
| 2014 |
Cole MD. MYC association with cancer risk and a new model of MYC-mediated repression. Cold Spring Harbor Perspectives in Medicine. 4: a014316. PMID 24985129 DOI: 10.1101/Cshperspect.A014316 |
0.466 |
|
| 2014 |
Hu T, Pan Q, Andrew AS, Langer JM, Cole MD, Tomlinson CR, Karagas MR, Moore JH. Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility. Biodata Mining. 7: 5. PMID 24725556 DOI: 10.1186/1756-0381-7-5 |
0.382 |
|
| 2014 |
Cowling VH, Turner SA, Cole MD. Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis. Oncogene. 33: 3519-27. PMID 24013231 DOI: 10.1038/Onc.2013.338 |
0.641 |
|
| 2013 |
Kaur M, Cole MD. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Research. 73: 695-705. PMID 23135913 DOI: 10.1158/0008-5472.Can-12-2522 |
0.607 |
|
| 2012 |
Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J, Moore JH, Lupien M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nature Genetics. 44: 1191-8. PMID 23001124 DOI: 10.1038/Ng.2416 |
0.582 |
|
| 2012 |
Doe MR, Ascano JM, Kaur M, Cole MD. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Research. 72: 949-57. PMID 22186139 DOI: 10.1158/0008-5472.Can-11-2371 |
0.726 |
|
| 2012 |
Schmucker AC, Wright JB, Cole MD, Brinckerhoff CE. Distal interleukin-1β (IL-1β) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression. The Journal of Biological Chemistry. 287: 1189-97. PMID 22102411 DOI: 10.1074/Jbc.M111.264077 |
0.553 |
|
| 2011 |
Savino M, Annibali D, Carucci N, Favuzzi E, Cole MD, Evan GI, Soucek L, Nasi S. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. Plos One. 6: e22284. PMID 21811581 DOI: 10.1371/Journal.Pone.0022284 |
0.349 |
|
| 2010 |
Cowling VH, Cole MD. Myc Regulation of mRNA Cap Methylation. Genes & Cancer. 1: 576-579. PMID 21170289 DOI: 10.1177/1947601910378025 |
0.442 |
|
| 2010 |
Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes & Development. 24: 1236-41. PMID 20551172 DOI: 10.1101/Gad.1920310 |
0.693 |
|
| 2010 |
Wright JB, Brown SJ, Cole MD. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Molecular and Cellular Biology. 30: 1411-20. PMID 20065031 DOI: 10.1128/Mcb.01384-09 |
0.611 |
|
| 2010 |
Cai Y, Jin J, Swanson SK, Cole MD, Choi SH, Florens L, Washburn MP, Conaway JW, Conaway RC. Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex. The Journal of Biological Chemistry. 285: 4268-72. PMID 20018852 DOI: 10.1074/Jbc.C109.087981 |
0.442 |
|
| 2009 |
Chandriani S, Frengen E, Cowling VH, Pendergrass SA, Perou CM, Whitfield ML, Cole MD. A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. Plos One. 4: e6693. PMID 19690609 DOI: 10.1371/Journal.Pone.0006693 |
0.757 |
|
| 2009 |
Cole MD, Cowling VH. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors. Oncogene. 28: 1169-75. PMID 19137018 DOI: 10.1038/Onc.2008.463 |
0.412 |
|
| 2008 |
Brown SJ, Cole MD, Erives AJ. Evolution of the holozoan ribosome biogenesis regulon. Bmc Genomics. 9: 442. PMID 18816399 DOI: 10.1186/1471-2164-9-442 |
0.423 |
|
| 2008 |
Cole MD, Cowling VH. Transcription-independent functions of MYC: regulation of translation and DNA replication. Nature Reviews. Molecular Cell Biology. 9: 810-5. PMID 18698328 DOI: 10.1038/Nrm2467 |
0.45 |
|
| 2008 |
Diop SB, Bertaux K, Vasanthi D, Sarkeshik A, Goirand B, Aragnol D, Tolwinski NS, Cole MD, Pradel J, Yates JR, Mishra RK, Graba Y, Saurin AJ. Reptin and Pontin function antagonistically with PcG and TrxG complexes to mediate Hox gene control. Embo Reports. 9: 260-6. PMID 18259215 DOI: 10.1038/Embor.2008.8 |
0.443 |
|
| 2008 |
Cowling VH, Cole MD. An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II. Oncogene. 27: 1327-32. PMID 17704800 DOI: 10.1038/Sj.Onc.1210734 |
0.489 |
|
| 2007 |
Cowling VH, Cole MD. Turning the tables: Myc activates Wnt in breast cancer. Cell Cycle (Georgetown, Tex.). 6: 2625-7. PMID 17726380 DOI: 10.4161/Cc.6.21.4880 |
0.43 |
|
| 2007 |
Rousseau B, Ménard L, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemière S, Canron X, Costet P, Cole M, Balabaud C, Bioulac-Sage P, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma Hepatology. 46: 1108-1118. PMID 17657734 DOI: 10.1002/Hep.21770 |
0.349 |
|
| 2007 |
Goodliffe JM, Cole MD, Wieschaus E. Coordinated regulation of Myc trans-activation targets by Polycomb and the Trithorax group protein Ash1. Bmc Molecular Biology. 8: 40. PMID 17519021 DOI: 10.1186/1471-2199-8-40 |
0.444 |
|
| 2007 |
Cowling VH, D'Cruz CM, Chodosh LA, Cole MD. c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Molecular and Cellular Biology. 27: 5135-46. PMID 17485441 DOI: 10.1128/Mcb.02282-06 |
0.451 |
|
| 2007 |
Cowling VH, Cole MD. HATs off to capping: a new mechanism for Myc. Cell Cycle (Georgetown, Tex.). 6: 907-9. PMID 17404507 DOI: 10.4161/Cc.6.8.4123 |
0.432 |
|
| 2007 |
Cowling VH, Cole MD. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Molecular and Cellular Biology. 27: 2059-73. PMID 17242204 DOI: 10.1128/Mcb.01828-06 |
0.417 |
|
| 2007 |
Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Research. 67: 501-10. PMID 17234757 DOI: 10.1158/0008-5472.Can-05-4571 |
0.33 |
|
| 2007 |
Cowling VH, Cole MD. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation. Oncogene. 26: 3582-6. PMID 17146437 DOI: 10.1038/Sj.Onc.1210132 |
0.415 |
|
| 2006 |
Cowling VH, Cole MD. Mechanism of transcriptional activation by the Myc oncoproteins. Seminars in Cancer Biology. 16: 242-52. PMID 16935524 DOI: 10.1016/J.Semcancer.2006.08.001 |
0.45 |
|
| 2006 |
Cowling VH, Chandriani S, Whitfield ML, Cole MD. A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest. Molecular and Cellular Biology. 26: 4226-39. PMID 16705173 DOI: 10.1128/Mcb.01959-05 |
0.762 |
|
| 2006 |
Cole MD, Nikiforov MA. Transcriptional activation by the Myc oncoprotein. Current Topics in Microbiology and Immunology. 302: 33-50. PMID 16620024 DOI: 10.1007/3-540-32952-8_2 |
0.321 |
|
| 2005 |
Goodliffe JM, Wieschaus E, Cole MD. Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila. Genes & Development. 19: 2941-6. PMID 16357214 DOI: 10.1101/Gad.1352305 |
0.358 |
|
| 2005 |
LeRoy G, Carroll R, Kyin S, Seki M, Cole MD. Identification of RecQL1 as a Holliday junction processing enzyme in human cell lines. Nucleic Acids Research. 33: 6251-7. PMID 16260474 DOI: 10.1093/Nar/Gki929 |
0.303 |
|
| 2005 |
Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, Lüscher B, Dittrich O, Tagami H, Nakatani Y, McGee M, et al. A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions. Molecular and Cellular Biology. 25: 6178-98. PMID 15988028 DOI: 10.1128/Mcb.25.14.6178-6198.2005 |
0.417 |
|
| 2003 |
Nikiforov MA, Popov N, Kotenko I, Henriksson M, Cole MD. The Mad and Myc basic domains are functionally equivalent. The Journal of Biological Chemistry. 278: 11094-9. PMID 12538578 DOI: 10.1074/jbc.M212298200 |
0.395 |
|
| 2002 |
Dugan KA, Wood MA, Cole MD. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis. Oncogene. 21: 5835-43. PMID 12185582 DOI: 10.1038/sj.onc.1205763 |
0.507 |
|
| 2002 |
Nikiforov MA, Chandriani S, O'Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM, Cole MD. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Molecular and Cellular Biology. 22: 5793-800. PMID 12138190 DOI: 10.1128/Mcb.22.16.5793-5800.2002 |
0.758 |
|
| 2002 |
Nikiforov MA, Chandriani S, Park J, Kotenko I, Matheos D, Johnsson A, McMahon SB, Cole MD. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Molecular and Cellular Biology. 22: 5054-63. PMID 12077335 DOI: 10.1128/Mcb.22.14.5054-5063.2002 |
0.774 |
|
| 2002 |
Kulesza CA, Van Buskirk HA, Cole MD, Reese JC, Smith MM, Engel DA. Adenovirus E1A requires the yeast SAGA histone acetyltransferase complex and associates with SAGA components Gcn5 and Tra1. Oncogene. 21: 1411-22. PMID 11857084 DOI: 10.1038/Sj.Onc.1205201 |
0.77 |
|
| 2002 |
Park J, Wood MA, Cole MD. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Molecular and Cellular Biology. 22: 1307-16. PMID 11839798 DOI: 10.1128/Mcb.22.5.1307-1316.2002 |
0.59 |
|
| 2001 |
Park J, Kunjibettu S, McMahon SB, Cole MD. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes & Development. 15: 1619-24. PMID 11445536 DOI: 10.1101/Gad.900101 |
0.401 |
|
| 2001 |
Lang SE, McMahon SB, Cole MD, Hearing P. E2F transcriptional activation requires TRRAP and GCN5 cofactors. The Journal of Biological Chemistry. 276: 32627-34. PMID 11418595 DOI: 10.1074/jbc.M102067200 |
0.336 |
|
| 2000 |
Nikiforov MA, Kotenko I, Petrenko O, Beavis A, Valenick L, Lemischka I, Cole MD. Complementation of Myc-dependent cell proliferation by cDNA expression library screening. Oncogene. 19: 4828-31. PMID 11039899 DOI: 10.1038/Sj.Onc.1203880 |
0.32 |
|
| 2000 |
Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Molecular Cell. 5: 321-30. PMID 10882073 DOI: 10.1016/S1097-2765(00)80427-X |
0.539 |
|
| 2000 |
McMahon SB, Wood MA, Cole MD. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Molecular and Cellular Biology. 20: 556-62. PMID 10611234 DOI: 10.1128/Mcb.20.2.556-562.2000 |
0.594 |
|
| 1998 |
Yuan J, Tirabassi RS, Bush AB, Cole MD. The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX. Oncogene. 17: 1109-18. PMID 9764821 DOI: 10.1038/sj.onc.1202036 |
0.352 |
|
| 1998 |
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 94: 363-74. PMID 9708738 DOI: 10.1016/S0092-8674(00)81479-8 |
0.77 |
|
| 1996 |
Hofmann TJ, Cole MD. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogene. 13: 617-24. PMID 8760303 |
0.357 |
|
| 1995 |
Brough DE, Hofmann TJ, Ellwood KB, Townley RA, Cole MD. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Molecular and Cellular Biology. 15: 1536-44. PMID 7862146 |
0.37 |
|
| 1990 |
Prendergast GC, Diamond LE, Dahl D, Cole MD. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Molecular and Cellular Biology. 10: 1265-9. PMID 2406566 |
0.586 |
|
| 1989 |
Coppola JA, Parker JM, Schuler GD, Cole MD. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene. Molecular and Cellular Biology. 9: 1714-20. PMID 2657403 |
0.322 |
|
| 1989 |
Mango SE, Schuler GD, Steele ME, Cole MD. Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. Molecular and Cellular Biology. 9: 3482-90. PMID 2477687 |
0.336 |
|
| 1989 |
Prendergast GC, Cole MD. Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Molecular and Cellular Biology. 9: 124-34. PMID 2467185 |
0.599 |
|
| 1986 |
Cole MD. Activation of the c-myc oncogene. Basic Life Sciences. 38: 399-406. PMID 3741337 |
0.331 |
|
| 1986 |
Coppola JA, Cole MD. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature. 320: 760-3. PMID 3458027 DOI: 10.1038/320760a0 |
0.311 |
|
| 1984 |
Keath EJ, Caimi PG, Cole MD. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell. 39: 339-48. PMID 6498938 DOI: 10.1016/0092-8674(84)90012-6 |
0.316 |
|
| Show low-probability matches. |